Insight

EGFR-mutated oligo-organ metastatic NSCLC, summarised by Katsuaki Maehara

Katsuaki Maehara/X

Oct 25, 2024, 16:19

EGFR-mutated oligo-organ metastatic NSCLC, summarised by Katsuaki Maehara

Katsuaki Maehara ,Director of Medical Education Colleagues, shared a post on X:

“ EGFR-mutated oligo-organ metastatic NSCLC
A murticenter, randomized, controlled, Phase III
First-line EGFR-TKIs, concurrent TRT improves the PFS & OS.

Katsuaki Maehara

TKI + TRT – Higher incidence of severe TRAEs.

EGFR-mutated oligo-organ metastatic NSCLC, summarised by Katsuaki Maehara

Thoracic Radiotherapy Improves the Survival in Patients With EGFR-Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial

Authors: Hongfu Sun, Minghao Li, Wei Huang, Jian Zhang, Shihong Wei, Yongjing Yang, Zhongtang Wang, Shucheng Ye, Heyi Gong, Yaowen Zhang, Jie Li,Haixia Song, Lifang Wang, Xiangming Chen, Haiqun Lin, Gaofeng Ding, Hongwei Li, Anping Zheng, Xuezhen Ma, ShaoShui Chen, Liping Liu, Kaixian Zhang, Chengrui Fu,Wenzhi Liu, Jing Wang, Xiaqin Zhang, Tingting Liu, Dan Han, Qian Zhao, Peipei Wu, Qianqian Yuan,LiJun Tian, Ping Zhang, Xueqin Wu, Fei Chen, Zicheng Zhang, and Baosheng Li.

Katsuaki Maehara

Anping Zheng Baosheng Li cancer cancer awareness cancer care Chengrui Fu Dan Han Fei Chen fight against cancer Gaofeng Ding Global fight against cancer Haiqun Lin Haixia Song Heyi Gong Hongfu Sun Hongwei Li Jian Zhang Jie Li Jing Wang Kaixian Zhang Katsuaki Maehara Lifang Wang LiJun Tian Liping Liu metastatic NSCLC Minghao Li NSCLC OncoDaily Oncology Peipei Wu Ping Zhang Qian Zhao Qianqian Yuan ShaoShui Chen Shihong Wei Shucheng Ye Tingting Liu Wei Huang Wenzhi Liu Xiangming Chen Xiaqin Zhang Xueqin Wu Xuezhen Ma Yaowen Zhang Yongjing Yang Zhongtang Wang Zicheng Zhang

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage